GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026
22

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated July 1, 2026

Introduction:

Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves DEN for patients with inadequate clinical response, immediate DEN may accelerate recovery by achieving earlier clearance of necrotic material.

Why was this study needed?:

The ideal timing of DEN after EUS-guided drainage has not been established.

The drainage-oriented step-up approach delays necrosectomy until clinically indicated.

Earlier necrotic tissue removal may shorten recovery without increasing complications.

Randomized evidence comparing immediate versus on-demand DEN has been lacking.

Results:

In the multicenter WONDER-01 randomized trial, immediate DEN significantly shortened the time to clinical success compared with the conventional drainage-oriented step-up strategy. Technical success was similarly high in both groups, and rates of procedure-related adverse events and mortality were comparable. However, all patients assigned to immediate DEN underwent necrosectomy, whereas fewer than half of those managed with the step-up approach ultimately required the procedure, highlighting that many patients can recover with drainage alone.

Clinical Impact:

Immediate DEN offers faster clinical resolution without compromising safety, making it an attractive option for patients in whom rapid recovery is desirable. However, because the step-up approach avoids unnecessary necrosectomy in a substantial proportion of patients, it remains an efficient and less invasive strategy. Treatment decisions should therefore be individualized based on disease severity, clinical response, and local expertise.

Bottom Line:

Immediate endoscopic necrosectomy after EUS-guided drainage accelerates recovery without increasing adverse events but results in more necrosectomy procedures, supporting individualized selection between immediate and step-up treatment strategies.

Related Q&A

23

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns...

24

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large...

25

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity,...

26

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This...

27

Durable Endoscopic Partial Reversal of Roux-en-Y Gastric Bypass Using Parallel LAMS Septotomy: GIE | July 2026

Introduction: Although Roux-en-Y gastric bypass (RYGB) is an effective bariatric procedure, a small proportion of patients develop severe nutritional complications, refractory dumping syndrome, or other debilitating adverse events...

28

EUS Double Drainage for Malignant Dual Obstruction : Gut | Jul 2026

Introduction: Simultaneous malignant distal biliary obstruction (MDBO) and gastric outlet obstruction (GOO), commonly caused by advanced pancreatic, biliary, or duodenal cancers, presents a major palliative challenge. Conventional endoscopic...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer